Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POLATUZUMAB VEDOTIN for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,196 adverse event reports in the FDA FAERS database where POLATUZUMAB VEDOTIN was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for POLATUZUMAB VEDOTIN

Side Effect Reports % Deaths Hosp.
Disease progression 1,131 23.9% 234 146
Off label use 692 14.6% 97 113
Anaemia 344 7.3% 48 127
Blood lactate dehydrogenase increased 307 6.5% 66 49
Drug ineffective 305 6.4% 72 52
Neutropenia 303 6.4% 55 102
Death 295 6.2% 295 52
Covid-19 286 6.0% 71 116
Febrile neutropenia 286 6.0% 37 197
Pyrexia 285 6.0% 46 156
Thrombocytopenia 265 5.6% 56 103
Lymphoma 257 5.4% 32 11
Platelet count decreased 256 5.4% 47 77
Neutrophil count decreased 252 5.3% 35 97
Diffuse large b-cell lymphoma 249 5.3% 60 23

Other Indications for POLATUZUMAB VEDOTIN

Product used for unknown indication (282) B-cell lymphoma (281) Diffuse large b-cell lymphoma refractory (223) Non-hodgkin's lymphoma (169) Follicular lymphoma (159) Diffuse large b-cell lymphoma recurrent (98) Diffuse large b-cell lymphoma stage iv (76) Richter's syndrome (54) Lymphoma (48) Lymphoma transformation (33)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

POLATUZUMAB VEDOTIN Full Profile All Diffuse large b-cell lymphoma Drugs POLATUZUMAB VEDOTIN Demographics POLATUZUMAB VEDOTIN Timeline